UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Tilia Fiduciary Partners Inc.

Tilia Fiduciary Partners Inc. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,650 shares of the healthcare conglomerate’s stock after purchasing an additional 194 shares during the period. UnitedHealth Group accounts for about 1.5% of Tilia Fiduciary Partners Inc.’s holdings, making the stock its 27th biggest position. Tilia Fiduciary Partners Inc.’s holdings in UnitedHealth Group were worth $2,134,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Visionary Wealth Advisors increased its position in UnitedHealth Group by 3.2% during the fourth quarter. Visionary Wealth Advisors now owns 1,232 shares of the healthcare conglomerate’s stock worth $649,000 after buying an additional 38 shares during the period. MGO One Seven LLC raised its position in UnitedHealth Group by 28.0% in the 4th quarter. MGO One Seven LLC now owns 8,760 shares of the healthcare conglomerate’s stock valued at $4,612,000 after purchasing an additional 1,917 shares during the last quarter. Rench Wealth Management Inc. increased its stake in UnitedHealth Group by 87.3% in the fourth quarter. Rench Wealth Management Inc. now owns 3,352 shares of the healthcare conglomerate’s stock valued at $1,765,000 after purchasing an additional 1,562 shares during the period. Ethic Inc. boosted its stake in shares of UnitedHealth Group by 11.8% during the fourth quarter. Ethic Inc. now owns 72,396 shares of the healthcare conglomerate’s stock worth $38,114,000 after buying an additional 7,645 shares during the period. Finally, Putnam Investments LLC increased its position in UnitedHealth Group by 3.9% in the 4th quarter. Putnam Investments LLC now owns 1,775,918 shares of the healthcare conglomerate’s stock valued at $934,968,000 after acquiring an additional 66,180 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Trading Up 0.5 %

Shares of NYSE UNH traded up $3.06 during midday trading on Wednesday, reaching $584.64. 300,835 shares of the stock were exchanged, compared to its average volume of 3,930,796. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $607.94. The stock has a 50 day moving average price of $582.68 and a 200-day moving average price of $529.13. The company has a market capitalization of $539.87 billion, a P/E ratio of 35.55, a P/E/G ratio of 1.65 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the prior year, the business posted $6.14 earnings per share. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, September 25th. HSBC increased their price target on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Wells Fargo & Company increased their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Morgan Stanley upped their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Tuesday, October 1st. Two equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.